Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: July 26, 2017
What are the generic drug sources for phentermine hydrochloride and what is the scope of phentermine hydrochloride patent protection?
Phentermine hydrochloride is the generic ingredient in eleven branded drugs marketed by Vitarine, Able, Usl Pharma, Sandoz Inc, Tg United Labs, Sandoz, Ken Lifescience, Mast Mm, Abc Holding, Teva, Invagen Pharms, Aurolife Pharma Llc, Lannett, Sun Pharm Inds, Camall, Elite Labs Inc, Ivax Pharms, Upsher-smith Labs, Solvay, Kvk Tech Inc, Watson Labs, Polygen Pharms, Ferndale Labs, Duramed Pharms Barr, Elite Labs, Ingenus Pharms Nj, Glaxosmithkline, Mikah Pharma, Lannett Holdings Inc, Zydus Pharms Usa Inc, Shire Richwood, Barr, Kvk Tech, Actavis Elizabeth, Prinston Inc, Tg United Inc, Citius Pharms, Sun Pharm Inds Inc, Avanthi Inc, and Vivus, and is included in one hundred NDAs. There are fourteen patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.| Tradenames: | 11 |
| Patents: | 14 |
| Applicants: | 40 |
| NDAs: | 100 |
| Drug Master File Entries: see list | 17 |
| Suppliers / Packagers: see list | 46 |
| Bulk Api Vendors: see list | 24 |
| Clinical Trials: see list | 2,274 |
| Patent Applications: see list | 1,035 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | phentermine hydrochloride at DailyMed |
| Drug Class | Sympathomimetic Amine Anorectic |
| Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | CAPSULE;ORAL | 086945-001 | Jul 20, 1983 | AA | RX | No | Yes | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Vivus | QSYMIA | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580-001 | Jul 17, 2012 | RX | Yes | No | ► Subscribe | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
Citius Pharms | SUPRENZA | phentermine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 202088-001 | Jun 13, 2011 | DISCN | No | No | ► Subscribe | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
Sandoz | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | TABLET;ORAL | 085689-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
Tg United Labs | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | CAPSULE;ORAL | 086732-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Country | Document Number | Estimated Expiration | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Germany | 69834255 | ► Subscribe | |||||||||||||||||||||||||||
| European Patent Office | 2254558 | ► Subscribe | |||||||||||||||||||||||||||
| Japan | 2001510785 | ► Subscribe | |||||||||||||||||||||||||||
| Spain | 2263216 | ► Subscribe | |||||||||||||||||||||||||||
| Austria | 323467 | ► Subscribe | |||||||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,136 others who get our Drug Patent Expiration Alerts:
